Release date: 2016-05-30
Introduction: Cardiovascular disease is the number one cause of death worldwide. The number of people dying from cardiovascular disease every year in the world is as high as 15 million, accounting for 20-30% of the total number of deaths worldwide. It is a group of heart and blood vessel disorders, including: coronary heart disease, cerebrovascular disease, peripheral vascular disease, rheumatic heart disease, congenital heart disease, deep vein thrombosis and pulmonary embolism.
Current status of cardiovascular disease in China
On May 10, the National Cardiovascular Center released the China Cardiovascular Disease Report 2015. According to the report, at present, cardiovascular deaths account for the first cause of total deaths in urban and rural residents in China, with 44.6% in rural areas and 42.51% in urban areas. The burden of cardiovascular disease is increasing, and it has become a major public health problem. The number of cardiovascular patients will continue to grow rapidly in the next 10 years.
Over the years, cardiovascular mortality has been high:
In 2015, the cause of death in rural and urban areas of China is shown in the figure below. Cardiovascular disease has become the leading cause of death.
Whether in urban or rural areas, the mortality rate of coronary heart disease is generally on the rise.
The mortality rate of myocardial infarction is also on the rise.
Treatment of cardiovascular disease
Interventional treatment related equipment
01 What is interventional therapy?
Interventional therapy is a new type of diagnosis and treatment of cardiovascular disease. After puncture of the blood vessels in the body, it is sent to the cardiac catheter under the continuous subtraction of digital subtraction, and the diagnosis and treatment of heart disease is carried out through specific cardiac catheter operation techniques. Diagnosis and treatment methods.
At present, interventional therapy has become one of the three modern medical treatment methods along with traditional medical treatment and surgical treatment.
02 Types of interventional instruments
Take the bracket as an example
The vascular stent refers to the expansion of the luminal balloon, and the internal stent is placed in the lesion to achieve the support of the stenotic occlusion vessel, reduce the elastic retraction of the blood vessel and reshape the shape, and maintain the blood circulation of the lumen. Some internal stents also have the effect of preventing restenosis.
classification:
According to the site of action, it is divided into: coronary stent, cerebral vascular stent, renal artery stent, and aortic stent.
According to the design, it is divided into: wall stent, tubular stent, wound stent, and annular stent.
Development status:
(Current stents have been developed to the fourth generation: degradable stents)
In addition, there are supporting catheters, guide wires, embolizations, etc., which will not be introduced.
Market situation of interventional therapy
Industry trend
01. The global market for interventional cardiovascular disease treatment has increased year by year, and by 2014, it has exceeded the $20 billion mark.
02. The use rate of cardiovascular stents in China is increasing year by year, and the trend is more obvious.
03. The proportion of the first-generation stent market has decreased year by year, which corresponds to the increase in the proportion of the third-generation stent market, which is now over 50%.
04. From 2010 to 2014, the proportion of imported stents in the domestic market has been between 35% and 40%, slightly decreasing in 2015; from the perspective of stent type, in 2015, the most advanced "biodegradable stent" All rely on imports.
05. The proportion, use and evaluation of domestically used stent brands in 2015, among which domestic brands have the largest proportion of micro-invasive products (domestic in the red box).
2015 National Coronary Heart Disease Intervention Data
In 2015, the number of percutaneous coronary intervention (PCI) in China was 567,583.
(Source: Peking University First Hospital)
The average number of stents per patient was basically the same as in previous years, and it was 1.50 in 2015.
(Source: Peking University First Hospital)
Investment and financing
Global ranking of investment institutions in the field of cardiovascular stents:
In the company's financing rankings, many Chinese companies rank high in the world:
Global cardiovascular sector company ranking
Top 10 global cardiovascular companies
In the subdivision of intervention, the number of Chinese interventional devices companies has an absolute advantage.
Typical company
Founded in 1949 and headquartered in Minneapolis, Minnesota, USA, Medtronic, Inc. is the world's leading medical technology company dedicated to providing lifelong treatment options for patients with chronic conditions.
The largest in the cardiovascular field - providing complete minimally invasive intervention products, including coronary stents, stent grafts, angioplasty balloons, guiding catheters, guidewires, and treatment of coronary artery disease, peripheral blood vessels, Ancillary products for intravascular and neurovascular diseases.
Source: MacKota Medical Finishing
Organic Peeled Garlic,Organic Fresh Peeled Garlic Cloves,Roasted Garlic Cloves Peeled,Organic Peeled Garlic For Sale
shandong changrong international trade co.,ltd. , https://www.cragriculture.com